Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
(2012) EUROPEAN JOURNAL OF CANCER. 48(16). p.2983-2992
Please use this url to cite or link to this publication:
http://hdl.handle.net/1854/LU-3052342
- author
- Jaine K Blayney, Giovanni L Ceresoli, Bruno Castagneto, Mary ER O'Brien, Baktiar Hasan, Richard Sylvester, Robin Rudd, Jeremy Steele, Sara Busacca, Camillo Porta, Luciano Mutti, Kenneth J O'Byrne, Paula Scullin, Rabab Gaafar, Paul Baas, Jan Van Meerbeeck UGent and Dean A Fennell
- organization
- year
- 2012
- type
- journalArticle (original)
- publication status
- published
- subject
- keyword
- CANCER COOPERATIVE GROUP, prognosis, mesothelioma, Landmark analysis, survival, PEMETREXED PLUS CARBOPLATIN, PROGRESSION-FREE SURVIVAL, PHASE-II TRIALS, LUNG-CANCER, MALIGNANT MESOTHELIOMA, TUMOR RESPONSE, EORTC, VINORELBINE, CISPLATIN
- journal title
- EUROPEAN JOURNAL OF CANCER
- Eur. J. Cancer
- volume
- 48
- issue
- 16
- pages
- 2983 - 2992
- Web of Science type
- Article
- Web of Science id
- 000310569100006
- JCR category
- ONCOLOGY
- JCR impact factor
- 5.061 (2012)
- JCR rank
- 36/196 (2012)
- JCR quartile
- 1 (2012)
- ISSN
- 0959-8049
- DOI
- 10.1016/j.ejca.2012.05.018
- language
- English
- UGent publication?
- yes
- classification
- A1
- copyright statement
- I have transferred the copyright for this publication to the publisher
- id
- 3052342
- handle
- http://hdl.handle.net/1854/LU-3052342
- date created
- 2012-11-13 14:42:22
- date last changed
- 2016-12-19 15:43:35
@article{3052342,
author = {Blayney, Jaine K and Ceresoli, Giovanni L and Castagneto, Bruno and O'Brien, Mary ER and Hasan, Baktiar and Sylvester, Richard and Rudd, Robin and Steele, Jeremy and Busacca, Sara and Porta, Camillo and Mutti, Luciano and O'Byrne, Kenneth J and Scullin, Paula and Gaafar, Rabab and Baas, Paul and Van Meerbeeck, Jan and Fennell, Dean A},
issn = {0959-8049},
journal = {EUROPEAN JOURNAL OF CANCER},
keyword = {CANCER COOPERATIVE GROUP,prognosis,mesothelioma,Landmark analysis,survival,PEMETREXED PLUS CARBOPLATIN,PROGRESSION-FREE SURVIVAL,PHASE-II TRIALS,LUNG-CANCER,MALIGNANT MESOTHELIOMA,TUMOR RESPONSE,EORTC,VINORELBINE,CISPLATIN},
language = {eng},
number = {16},
pages = {2983--2992},
title = {Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma},
url = {http://dx.doi.org/10.1016/j.ejca.2012.05.018},
volume = {48},
year = {2012},
}
- Chicago
- Blayney, Jaine K, Giovanni L Ceresoli, Bruno Castagneto, Mary ER O’Brien, Baktiar Hasan, Richard Sylvester, Robin Rudd, et al. 2012. “Response to Chemotherapy Is Predictive in Relation to Longer Overall Survival in an Individual Patient Combined-analysis with Pleural Mesothelioma.” European Journal of Cancer 48 (16): 2983–2992.
- APA
- Blayney, J. K., Ceresoli, G. L., Castagneto, B., O’Brien, M. E., Hasan, B., Sylvester, R., Rudd, R., et al. (2012). Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. EUROPEAN JOURNAL OF CANCER, 48(16), 2983–2992.
- Vancouver
- 1.Blayney JK, Ceresoli GL, Castagneto B, O’Brien ME, Hasan B, Sylvester R, et al. Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma. EUROPEAN JOURNAL OF CANCER. 2012;48(16):2983–92.
- MLA
- Blayney, Jaine K, Giovanni L Ceresoli, Bruno Castagneto, et al. “Response to Chemotherapy Is Predictive in Relation to Longer Overall Survival in an Individual Patient Combined-analysis with Pleural Mesothelioma.” EUROPEAN JOURNAL OF CANCER 48.16 (2012): 2983–2992. Print.